Pentasa 01
Pentasa Capsule
Product Images NDC 54092-191
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pentasa (NDC 54092-191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (250 mg Capsule Bottle Label)
Pentasa is an extended-release capsule distributed by Takeda Pharmaceuticals. This medication is a trademark of ervring BV used under license. The information contained in the text is limited and does not provide extensive detail other than the information on the medication and its distributor.*
Principal Display Panel (500 mg Capsule Bottle Label)
Principal Display Panel (500 mg Capsule Sample Carton)
Pentasa® (mesalamine) is a medicine that comes in the form of Controlled-Release Capsules. The Dosage and Administration of the medicine are written on the package insert, making the drug useful for curing many ailments. However, the label warns that the medicine should be kept out of the reach of children and should be stored at 25°C (50-85°F). The other information about the medicine is not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
